Has Gary Snyder, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,480 in general payments to Gary Snyder, MD across 185 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gary Snyder, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gary Snyder, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gary Snyder, MD

Otolaryngology/Facial Plastic Surgery · Plainview, NYNPI 1427016500

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,302 of the $8,480 with a category attached, or 62.5%. 20 manufacturers reported payments, led by Optinose US, Inc. at 53.0% of the total. Reporting peaked in 2019 at $4,454 and has fallen 80.3% since, to $878 in 2024.

$8,480in general payments, 2019–2025

Across 185 payments — averaging $45.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Optinose US, Inc.$4K
Regeneron Healthcare Solutions, Inc.$801
Sanofi$630
GSK$529
Stryker$522
Alk-abello, Inc$449
plus $1K from 14 others

What the payments were for

Consulting fees$2,50029%
Travel & lodging$6788%
Food & beverage$5,30263%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Optinose US, Inc.	51	$4,498
Regeneron Healthcare Solutions, Inc.	28	$801
Sanofi	22	$630
GSK	27	$529
Stryker	6	$522
Alk-abello, Inc	13	$449
Kaleo, Inc.	9	$209
Neurent Medical Limited	1	$172
Aerin Medical Inc.	6	$170
Inspire Medical Systems, Inc.	3	$150
Amgen	5	$105
Hikma Pharmaceuticals USA	3	$42
Merck	2	$39
Novartis	2	$37
Glenmark Therapeutics Inc.	2	$25
Medtronic	1	$24
AstraZeneca	1	$23
Acclarent, Inc	1	$21
Pfizer	1	$19
AbbVie	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Xhance$3,417
DUPIXENT$331
CLARIFIX$263
NEUROMARK Device$172
NEUROMARK Radiofrequency Console$172
Odactra$139
Inspire$121
ENTELLUS - XPRESS ENT DILATION SYSTEM$113

How this compares

$8,480 in reported general payments places this provider in the 80th percentile of 48 otolaryngology/facial plastic surgery providers in New York.

See all otolaryngology/facial plastic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$244,962

Medicare patients

832

Services billed

2,200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluocinolone Acetonide Oil	68	$2,804
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	24	$2,464
Ipratropium Bromide	67	$2,061
Mometasone Furoate	60	$1,046
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort	19	$770
Azelastine Hcl	29	$591
Pantoprazole Sodium	41	$488
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	54	$438
Fluticasone Propionate	29	$435
Methylprednisolone	65	$425
Famotidine	36	$406
Montelukast Sodium	24	$328
Omeprazole	42	$326
Clarithromycin	22	$296
Meclizine Hcl	19	$217

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Plainview

Jennifer LevineNew York$454K
Jason MocheNew York$439K
Stephen WarmanForest Hills$50K
Stacey SilversNew York$42K
Dara LiottaNew York$17K
Amar SuryadevaraSyracuse$11K
Sean KennedyGlens Falls$10K
Jordon GrubeAlbany$9K
Eliot DanzigerLevittown$7K
Matthew DicksonGlens Falls$7K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →